European consensus conference on faecal microbiota transplantation in clinical practice

By G. Cammarota, G. Ianiro, Herbert Tilg, M. Rajilić-Stojanović, P. Kump, R. Satokari, Harry Sokol, P. Arkkila, C. Pintus, A. Hart and 18 more. Gut, 2017

1,059 citations recorded by the source corpus.

Faecal microbiota transplantation (FMT) is an important therapeutic option for Clostridium difficile infection. Promising findings suggest that FMT may play a role also in the management of other disorders associated with the alteration of gut microbiota. Although the health community is assessing FMT with renewed interest and patients are becoming more aware, there are technical and logistical issues in establishing such a non-standardised treatment into the clinical practice with safety and proper governance. In view of this, an evidence-based recommendation is needed to drive the practical implementation of FMT. In this European Consensus Conference, 28 experts from 10 countries collaborated, in separate working groups and through an evidence-based process, to provide statements on the following key issues: FMT indications; donor selection; preparation of faecal material; clinical management and faecal delivery and basic requirements for implementing an FMT centre. Statements developed by each working group were evaluated and voted by all members, first through an electronic Delphi process, and then in a plenary consensus conference. The recommendations were released according to best available evidence, in order to act as guidance for physicians who plan to implement FMT, aiming at supporting the broad availability of the procedure, discussing other issues relevant to FMT and promoting future clinical research in the area of gut microbiota manipulation. This consensus report strongly recommends the implementation of FMT centres for the treatment of C. difficile infection as well as traces the guidelines of technicality, regulatory, administrative and laboratory requirements.

Subfields: Epidemiology, Infectious Diseases, Surgery

View Paper: https://www.semanticscholar.org/paper/b538185af365a80b933dec8551fc6f4e6ceeee99

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

J. Ramírez
L. B. Bustos Fernandez
Ronald D. Hills
A. Maruy
V. Sdepanian
H. Cohen
Benjamin A Pontefract
Hillary R. Mishcon

Citations in the corpus

Gut Microbiome: Profound Implications for Diet and Disease (2019, background): “Fecal microbiota transplantation (FMT) is yet another therapeutic option, which involves the engraftment of microbes from a healthy donor [73].”
Antibiotics as Major Disruptors of Gut Microbiota (2020, background): “November 2020 | Volume 10 | Article 572912 In 2011, 453,000 cases of CDI and 29,000 CDI-associated deaths were recorded in the US (Leffler and Lamont, 2015).”